Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling...
Nasal Swab Might Predict How Severe COVID Will Be
A simple nasal swab might help doctors predict the severity of a person’s COVID infection, a new study suggests.More than 70% of people with mild or...
Prevalence of Diabetes 15.8 Percent in U.S. Adults From 2021 to 2023
The prevalence of diabetes was 15.8 percent among U.S. adults during August 2021 to August 2023, according to a November data brief published by the National...
Low Zinc Levels Seen With Liver Cirrhosis, Hepatic Encephalopathy
Serum zinc is often deficient in patients with liver cirrhosis and hepatic encephalopathy (HE), according to a study published online in the September...
Nursing-Sensitive Quality Indicators Negatively Impacted by Pandemic
Rates for five nursing-sensitive quality indicators (NSIs) increased during the COVID-19 pandemic and have subsequently declined, according to a study...
Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
Lower abdominal visceral fat area (VFA), older age, and prolonged surgery are independent risk factors for developing postoperative neurogenic bladder...
Scientists Track Brain Function as Folks Watch Movies
A person’s brain performs an intricate juggling act while watching a movie, a new study demonstrates. Scans showed that 24 different brain networks...
Florida Fails to Pass Amendment Legalizing Recreational Weed
A ballot measure to legalize the recreational use of marijuana in the state of Florida failed on Tuesday. While 55.9% of Florida voters backed the proposed...
Abortion Rights Measures Pass in 7 States, Fail in 3
In election results that showed protecting women's reproductive freedoms matter to a majority of Americans, abortion rights measures passed in seven states...
Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application...
VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac
November 4, 2024 – Sacramento, CA, VitalityVita.com is voluntarily recalling lot 230811, Exp 8/11/25, of VitalityXtra Capsules and PeakMax Capsules...
Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac
November 4, 2024 – Sacramento, CA, Boulla LLC is voluntarily recalling lot YZM240406, Exp 04/05/27, of ZoomMax Capsules and ZapMax Capsules packaged...
Prepping for Colonoscopy? An Expert Offers Tips to Make Things Easier
Everyone knows that colonoscopies save lives, but that doesn't make drinking a lot of liquid laxatives in preparation for the procedure any less daunting. Luckily,...
FDA Warns Patients and Health Care Professionals Not to Use Compounded Drugs from Fullerton Wellness
FDA is warning patients and health care professionals not to use drugs compounded and distributed by Fullerton Wellness LLC, Ontario, Calif., and distributed...
Diadem Unveils Novel Findings on Early Alzheimer's Disease Detection Using p53-Specific Antibody at CTAD 2024
MILAN, Nov. 1, 2024. Diadem SpA, in partnership with researchers from the University of Texas Medical Branch, led by Prof. Rakez Kayed from the Mitchell...
Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs...
UCB Presents Encouraging Data on Bepranemab in Early Alzheimer’s Disease in Phase 2a Study at CTAD 2024
Results provide first evidence of biological and clinical effect of a mid-domain tau-targeting disease-modifying therapy1 In full study population...
Monthly News Roundup - October 2024
FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev (foscarbidopa...
Recently Added
Recently added consumer and prescribing information: Emrosi, Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza, Pavblu, Livdelzi, Yorvipath, Crexont
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Emrosi Emrosi (minocycline hydrochloride) is a low-dose, modified-release capsule formulation of the approved tetracycline-class drug minocycline...
- Orlynvah Orlynvah (sulopenem etzadroxil and probenecid) is a penem antibacterial and renal tubular transport inhibitor combination used for the...
- Vyloy Vyloy (zolbetuximab-clzb) is a claudin 18.2-directed cytolytic antibody used for the combination treatment of patients with HER2-negative...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...